Cited by 156Lipid metabolism and disordersLipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.

Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins

Cohn, Jeffrey S., Marcoux, Caroline, Davignon, Jean·1999·Arteriosclerosis, Thrombosis, and Vascular Biology

Open this paper in CoChat — free account

Abstract

Abstract —Triglyceride-rich lipoprotein (TRL) remnants are formed in the circulation when apolipoprotein (apo) B-48–containing chylomicrons of intestinal origin or apoB-100–containing VLDL of hepatic origin are converted by lipoprotein lipase, and to a lesser extent by hepatic lipase, into smaller and more dense particles. Compared with their nascent precursors, TRL remnants are depleted of triglyceride, phospholipid, and C apolipoproteins and are enriched in cholesteryl esters and apoE. They can thus be identified, separated, and/or quantified in plasma according to their density, charge, size, specific lipid components, apolipoprotein composition, and/or apolipoprotein immunospecificity. Each of these approaches has contributed to our current understanding of the compositional characteristics of TRL remnants and their potential to promote atherosclerosis. An ongoing search is nevertheless under way for more accurate and clinically applicable remnant lipoprotein assays that will be able to better define coronary artery disease risk in patients with hypertriglyceridemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.atv.19.10.2474

Cites

186 of 186 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
The Role of Lipids and Lipoproteins in Atherosclerosis
Gofman, J. W., Lindgren, F. T., Elliott, H. A., Mantz, W., Hewitt, J. E., Strisower, B., Herring, V. V., & Lyon, T. P. (1950) · Science · doi:10.1126/science.111.2877.166 · Cited by 921
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
Watts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90863-x · Cited by 843

Show all 187 references

Research works printed but not linked: 51

10.1001/jama.1993.03500230097036 · DOI
10.1161/circ.97.11.1027 · DOI
10.1161/res.80.6.819 · DOI
Eisenberg S. Remnant lipoprotein metabolism. In: Crepaldi G Tiengo A Manzato E eds. Diabetes Obesity and Hyperlipidemia: V. The Plurimetabolic Syndrome. New York NY: Elsevier Science Publishers; 1993;7–14.
Lindgren FT Jensen LC Hatch FT. The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ ed. Blood Lipids and Lipoproteins . New York NY: John Wiley-Interscience; 1972:181–274.
1979, Artery., 5, 495
10.1161/atv91.14.11.7947593 · DOI
10.1161/circ.75.1.3791598 · DOI
10.1161/atvb.16.5.697 · DOI
10.1161/circ.64.6.7296792 · DOI
10.1161/circ.71.5.3986978 · DOI
1987, Lancet., 1, 62
10.1161/circ.88.6.8252689 · DOI
10.1161/circ.69.2.6360414 · DOI
10.1161/circ.95.8.2022 · DOI
10.1161/atvb.17.11.2630 · DOI
10.1161/atv91.11.5.1680391 · DOI
10.1161/atv91.13.9.8364012 · DOI
10.1161/atv91.11.2.1998641 · DOI
10.1161/atvb.17.9.1707 · DOI
10.1161/atvb.15.2.199 · DOI
10.1161/atv91.11.3.2029503 · DOI
10.1161/atvb.15.11.1829 · DOI
10.1161/atvb.15.12.2122 · DOI
10.1161/atv91.12.6.1534257 · DOI
1985, Arteriosclerosis., 1985, 371
10.1161/atvb.16.1.149 · DOI
10.1161/atvb.17.4.715 · DOI
10.1161/atv91.14.1.8274468 · DOI
10.1161/atv91.14.1.8274470 · DOI
10.1161/atv91.14.4.7511933 · DOI
1985, J Clin Invest., 75, 383
10.1161/atvb.15.7.963 · DOI
10.1161/atv91.13.5.8485124 · DOI
10.1161/circ.81.2.2404631 · DOI
10.1161/circ.90.1.8026027 · DOI
10.1161/circ.88.1.8319334 · DOI
10.1161/atv91.12.11.1420093 · DOI
1996, J Clin Ligand Assay., 19, 177
1998, Cin Chem., 44, 1224
1996, Jpn J Nephrol., 38, 220
1995, Ann N Y Acad Sci, 748, 595
1995, Ann N Y Acad Sci, 748, 441
1996, Thromb Res., 5, 583
10.1161/circ.97.25.2519 · DOI
10.1161/atvb.15.5.551 · DOI
10.1161/atv91.12.1.1731859 · DOI
10.1161/atvb.15.4.534 · DOI
10.1161/atvb.17.3.498 · DOI
10.1161/atv91.14.12.7981177 · DOI
10.1161/atvb.16.4.533 · DOI

Sorted by citations

Items 101–156 of 156

Rare PPARA variants and extreme response to fenofibrate in the Genetics of Lipid-Lowering Drugs and Diet Network Study
Irvin, M. R., Zhang, Q., Kabagambe, E. K., Perry, R. T., Straka, R. J., Tiwari, H. K., Borecki, I. B., Shimmin, L. C., Stuart, C., Zhong, Y., et al. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328351a486 · Cited by 13
Lipid composition in atheromatous plaque: evaluation of the lipid three-phase percentage
MARINELLO, E., Setacci, C., Giubbolini, M., Cinci, G., Frosi, B., Porcelli, B., & Terzuoli, L. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00185-1 · Cited by 13
Non‐High‐Density Lipoprotein Cholesterol: Why Lower Is Better
Garg, R., Vasamreddy, C. R., & Blumenthal, R. S. (2005) · Preventive Cardiology · doi:10.1111/j.1520-037x.2005.4077.x · Cited by 12
Postprandial Increase in Plasma Concentrations of Remnant-Like Particles: An Independent Risk Factor for Restenosis after Percutaneous Coronary Intervention
Oi, K., Shimokawa, H., Hirakawa, Y., Tashiro, H., Nakaike, R., Kozai, T., Ohzono, K., Yamamoto, K., Koyanagi, S., Okamatsu, S., et al. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200407000-00009 · Cited by 13
Hypertriglyceridemia in pregnancy does not contribute to the enhanced formation of remnant lipoprotein particles
Okazaki, M., Usui, S., Tokunaga, K., Nakajima, Y., Takeichi, S., Nakano, T., & Nakajima, K. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.10.008 · Cited by 12
Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function
Sakabe, K., Fukuda, N., Fukuda, Y., Wakayama, K., Nada, T., Morishita, S., Shinohara, H., & Tamura, Y. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.10.008 · Cited by 11
A rapid methodology for the isolation of intermediate-density lipoprotein: characterization of lipid composition and apoprotein content
McFarlane, C., Young, I. S., Hare, L. G., Mahon, G., & McEneny, J. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.10.010 · Cited by 10
Identification of molecular species of oxidized triglyceride in plasma and its distribution in lipoproteins
Shrestha, R., Hui, S., Miura, Y., Yagi, A., Takahashi, Y., Takeda, S., Fuda, H., & Chiba, H. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1088 · Cited by 10
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy
Toth, P. P., Bays, H. E., Brown, W. V., Catapano, A. L., Davidson, M. H., Farnier, M., Tomassini, J. E., Jensen, E. H., Polis, A. B., & Tershakovec, A. M. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.09.001 · Cited by 10
Remnant-like lipoproteins, hormone therapy, and angiographic and clinical outcomes: The Women's Angiographic Vitamin & Estrogen trial
Bittner, V., Tripputi, M., Hsia, J. A., Gupta, H., & Steffes, M. W. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.01.025 · Cited by 9
Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men
Chan, D. C., Watts, G. F., Ng, T. W., Uchida, Y., Sakai, N., Yamashita, S., & Barrett, P. H. R. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.05.009 · Cited by 9
Triglyceride-rich lipoprotein remnant levels and metabolism
Brinton, E. A., Nanjee, M. N., & Hopkins, P. N. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.001 · Cited by 9
Effect of Low Carbohydrate Diet (LCD) for Diabetic Patients withHypertriglycemia
Ebe, K., Bando, H., Muneta, T., Bando, M., & Yonei, Y. (2017) · Institutional Repositories DataBase (IRDB) · Cited by 7
Dietary virgin olive oil triacylglycerols as an independent determinant of very low-density lipoprotein composition
Perona, J. S., Cañizares, J., Montero, E., Sánchez-Domínguez, J. M., Pacheco, Y. M., & Ruiz-Gutiérrez, V. (2004) · Nutrition · doi:10.1016/j.nut.2004.03.008 · Cited by 8
Proteomic Analysis of Human Chylomicron Remnants Isolated by Apolipoprotein B-48 Immunoprecipitation
Masuda, D., Okada, T., Sairyou, M., Takafuji, K., Ohama, T., Koseki, M., Nishida, M., Sakata, Y., & Yamashita, S. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64920 · Cited by 7
Acute in vivo chylomicron metabolism and postalimentary lipoprotein alterations in normolipidemic male smokers
Zaratin, A. C. M., Bertolami, M. C., Faludi, A. Á., Rocha, J. C., Nunes, V. S., Nakandakare, E. R., Quintão, E. C. R., & de Faria, E. C. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00431-9 · Cited by 7
Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemias
Duvillard, L., CASLAKE, M. J., Petit, J., Vergès, B. L., Gambert, P., & Packard, C. J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.026 · Cited by 7
Short-term effects of low-dose atorvastatin on inflammatory status and lipid profiles in perimenopausal hypercholesterolemic, hypertriglyceridemic women
Ushiroyama, T., Nosaka, S., & Ueki, M. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.11.001 · Cited by 6
Remnant Lipoprotein Density Profiling by CsBiEDTA Density Gradient Ultracentrifugation
Chandra, R., & Macfarlane, R. D. (2005) · Analytical Chemistry · doi:10.1021/ac050775w · Cited by 6
Apolipoprotein E enrichment of immuno-separated chylomicron and chylomicron remnants following saturated fatty acids
Jackson, K. G., Wolstencroft, E. J., Bateman, P. A., Yaqoob, P., & Williams, C. M. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.07.001 · Cited by 6
Intestinal and Hepatic Uptake of Dietary Peroxidized Lipids and Their Decomposition Products, and Their Subsequent Effects on Apolipoprotein A1 and Paraoxonase1
Jiang, X., Deme, P., Gupta, R., Litvinov, D. Y., Burge, K. Y., Parthasarathy, S., & Narasimhulu, C. A. (2021) · Antioxidants · doi:10.3390/antiox10081258 · Cited by 6
Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end‐stage renal disease patients
Barbagallo, C. M., Noto, D., Cefalu, A. B., Ganci, A., Giammarresi, C., Panno, M. D., Cusumano, G., Greco, M., Gaudio, F. D., & Averna, M. R. (2014) · Hemodialysis International · doi:10.1111/hdi.12250 · Cited by 6
Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis
Zhang, B., Katafuchi, R., Arishima, H., Matsunaga, A., Rye, K., & Saku, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.04.026 · Cited by 6
Point-of-care monitoring of intracellular glutathione and serum triglyceride levels using a versatile personal glucose meter
Xu, J., Qiao, X., Zhang, J., Cheng, N., Sheng, Q., Zheng, J., Cao, W., Yue, T., & Lu, Y. (2019) · Analytical Methods · doi:10.1039/c8ay02709a · Cited by 5
The role of endothelium in atherogenesis: dependence of atherosclerosis development on the properties of vessel endothelium
Ns, P. (2020) · Medical academic journal · doi:10.17816/maj25755 · Cited by 6
Chylomicron Remnant Concentrations in Patients with Coronary Artery Disease
Orth, M., Dierkes, J., & Luley, C. H. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.099 · Cited by 5
Characterization of Lipids in Femoral Atheroma from Diabetic Patients and Their Use as Clinical Descriptors
NarvÃÂ¡ez-Rivas, M. N., Pérez-Ramírez, I.-F., & Gallardo, E. (2015) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000136 · Cited by 4
Consumption of low doses of fat prevents the postprandial rise in chylomicron particle concentration and remnant accumulation in healthy normolipidaemic males
James, A. P., & Mamo, J. C. L. (2012) · Journal of Nutritional Science · doi:10.1017/jns.2012.4 · Cited by 4
Regulation of fatty acid transport and storage: influence of acylation-stimulating protein
Cianflone, K., & Paglialunga, S. (2006) · Scandinavian Journal of Food & Nutrition · doi:10.1080/17482970601069185 · Cited by 4
Effects of a Fiber-Rich Nutritional Supplement on Postprandial Glycemic Response and Lipid Parameters in Overweight Adults with and without Impaired Fasting Glucose in India
Bhoite, R. (2020) · Journal of Diabetes & Metabolism · doi:10.35248/2155-6156.20.11.841 · Cited by 4
Capillary isotachophoresis study of lipoprotein network sensitive to apolipoprotein E phenotype. 1. ApoE distribution between lipoproteins
Dergunov, A. D., Ponthieux, A., Mel’kin, M. V., Lambert, D., Visvikis‐Siest, S., & Siest, G. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-0018-9 · Cited by 4
Remnant cholesterol and particle number of VLDL subfractions in coronary artery disease: Pros and cons
Johansen, M. Ø., Vedel‐Krogh, S., Nielsen, S. F., Afzal, S., Smith, G. D., & Nordestgaard, B. G. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120605 · Cited by 4
Increased intima-media thickness of the carotid artery in Japanese female type 2 diabetic patients with ‘midband lipoprotein’
Hosaka, S., Okada, Y., Maruyama, K., & Maruyama, D. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.032 · Cited by 3
Lipid‐Related Factors
Frayn, K. N., & Stanner, S. A. (2005) · doi:10.1002/9780470774663.ch3 · Cited by 3
Lipid disorders – the comparison between general population and haemodialyzed patients. Will the Oral Fat Tolerance Test improve the diagnostic?
Cader, A., Stępniewska, J., & Różański, J. (2022) · Acta Biochimica Polonica · doi:10.18388/abp.2020_6462 · Cited by 2
An improved method for the rapid assessment of persisting chylomicron remnant concentrations
Orth, M., Weinland-Wilken, C., Westphal, S., & Luley, C. H. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00233-8 · Cited by 2
A Proposal of The New Mechanism on Remnant Lipoprotein Formation and Clearance after Food Intake
Nakajima, K., & Tanaka, A. (2017) · Journal of Aging Science · doi:10.4172/2329-8847.1000173 · Cited by 1
Evaluation of atherogenic lipoprotein-cholesterol to HDL cholesterol ratio as a prognostic test for ST-segment elevation myocardial infarction
Li, J., Xu, W., Zhou, Z. G., Zhang, R.-L., Sun, T., Xu, H., & Wu, J. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.44801 · Cited by 1
Desirable Components of a Screening Lipid Profile
Emerson, J. F. (2003) · Laboratory Medicine · doi:10.1309/hd5y-8pa7-v0gk-ngy9 · Cited by 1
Oxidized lipid species in lipoproteins: Significance and analytical considerations
Shrestha, R., Chiba, H., & Hui, S. (2020) · doi:10.24508/mms.2020.06.003 · Cited by 1
Serum esterified cholesterol subfractions as a risk marker for coronary artery disease
Gulati, D., Aggrawal, M., Gopinath, M., & Harith, A. K. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns1.6263 · Cited by 1
Estudo comparativo do efeito de técnicas cirúrgicas para o tratamento da obesidade, Capella e Santoro II, sobre o peso, IMC e trigliceridemia periférica /
Milléo, F. Q. (2005) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Postprandial Triglyceride-rich Lipoprotein Composition and Size after Olive Oil
Cabello-Moruno, R., Perona, J. S., & Ruíz-Gutiérrez, V. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374420-3.00094-2
Monitoring of Lipids in Diabetes
Laker, M. F., & Neely, R. D. G. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0807
The role of B-glucan, plant stanols, and oxy(phyto)sterols in managing cardiovascular risk
Theuwissen, E. (2008) · Research Publications (Maastricht University) · doi:10.26481/dis.20081217et
Lipid Analysis for Important Clinical Conditions
Leary, E. T., & Carlson, T. H. (2000) · Encyclopedia of Analytical Chemistry · doi:10.1002/9780470027318.a0509m
Utilization of Lipoprotein Subfractions
Cromwell, W. C., & Otvos, J. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-533-6_15
Nutritional Factors Impacting Intestinal Lipid Metabolism Using a Model of Low Birth Weight Swine
Fontaine, M. A. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3dr2pq51
Triglyceride is Significantly Increased in Remnant Lipoproteins After Food Intake and its Association with Lipoprotein Lipase in the Plasma
Nakajima, K., Tokita, Y., & Tanaka, A. (2018) · Journal of Obesity and Diabetes · doi:10.33805/2638-812x.107
Intestinal Microbiota and Bacterial Translocation: Impact of Diet, Obesity and Insulin Resistance
Singh, V. P. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-gba2-gr59
冠疾患における高中性脂肪血症の重要性 : レムナントリポ蛋白の代謝と動脈硬化惹起性(1.メタボリックシンドロームの分子機序と治療の最前線,<特集II>第70回日本循環器学会学術集会)
藤岡, 由., 石川, 雄., & 光宏, 横. (2007) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.15.1_25
Regulation of fatty acid transport and storage: influence of acylation-stimulating protein
Cianflone, K., & Paglialunga, S. (2006) · Food & Nutrition Research · doi:10.3402/fnr.v50i0.1582
Biomarkers in Disease: Diabetes Methods, Discoveries and Applications
de Carvalho, L. S. F., Asari, A. I. A., Teles, B. S. B. D. S., Chaves‐Filho, A. B., & Yoshinaga, M. Y. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_20-1
Biomarkers in Disease: Diabetes Methods, Discoveries, and Applications
de Carvalho, L. S. F., Asari, A. I. A., Teles, B. S. B. D. S., Filho, A. D. B. C., & Yoshinaga, M. Y. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_20
Approches biochimique, épidémiologique et clinique du métabolisme intégré de la Lipoprotéine (a)
Blanchard, V. (2020) · theses.fr (ABES) · doi:10.70675/3ce7e0fdzecbaz4b18zaf08z34fb33c163ff
Association of remnant cholesterol with kidney outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
Gao, J., Wang, J.-Q., & Wang, Z.-L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1969361

Authors: Cohn, J. S., Marcoux, C., & Davignon, J.
Affiliations: Montreal Clinical Research Institute (CA)
ORCID: Cohn, Jeffrey S.
Davignon, Jean
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1999-10
Volume: 19
Issue: 10
Pages: 2474-2486
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/01.atv.19.10.2474
OpenAlex: W2162381401
Cited by: 156
References: 187
Citations by year: 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 7 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 5 · 2012: 3
FWCI: 1.09
Type: journal article
Language: en
Open access: closed
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: Heart and Stroke Foundation of Canada
Otsuka America
Medical Research Council Canada
Medical Research Council
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: atherogenic lipoproteins, apolipoprotein E, apolipoprotein B-48, apolipoprotein B-100, lipoprotein lipase, hepatic lipase, chylomicrons, VLDL, hypertriglyceridemia, coronary artery disease risk, atherosclerosis
MeSH terms: Arteriosclerosis, Humans, Lipoproteins, Triglycerides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks